3rd October 2018: Cancer care in the South of England took a significant step forward today with the opening of the Rutherford Cancer Centre Thames Valley.
21st August 2018: A new chapter in the provision of advanced cancer care in the North-East of England has started with the official opening of the Rutherford Cancer Centre North East.
8th August 2018: The provision of advanced cancer treatment in the South of England passed a key milestone today with the arrival of the first high energy proton beam therapy system in the region.
7th August 2018: The first patient to be treated with high energy proton beam therapy for breast cancer in the UK commenced treatment this week at the Rutherford Cancer Centre South Wales.
11th April 2018: Proton Partners International announced today it has treated the first patient in the UK with high energy proton beam therapy.
20th March 2018: Proton Partners International has been granted formal technical and regulatory approval from Healthcare Inspectorate Wales to begin treating patients with proton beam therapy at its Rutherford Cancer Centre in Wales.
12th March 2018: IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International, to install three Proteus®ONE* compact proton therapy solutions across the UK.
7th March 2018: Wales has shown ‘outstanding’ vision in helping to develop innovative proton beam therapy services for cancer patients.
22nd February 2018: Proton Partners International and Ion Beam Applications (IBA) Group, the world’s leading developers of high energy proton beam therapy centres and systems, have officially completed testing on the UK’s first high energy proton beam machine, the Proteus®ONE.
Proton Partners International has today announced plans to build a new £35 million cancer treatment centre in Liverpool.
The cancer centre will be built in the new £1 billion Paddington Village, part of Liverpool’s Knowledge Quarter (KQ).
This will be one of four centres built by Proton Partners International in the UK and will make the company the world’s largest developer of proton beam therapy centres. Proton Partners International is currently building three other UK cancer centres, in Newport, Northumberland and Reading, and is considering further sites.
The oncology centre, which will be known as The Rutherford Cancer Centre North West, will offer radiotherapy, chemotherapy and imaging from 2018, and proton beam therapy will be available in 2019.
Joe Anderson, Mayor of Liverpool, said: “We are delighted KQ Liverpool has been able to attract another prestigious development to Paddington Village.
“Momentum is really beginning to build for KQ Liverpool and we can expect more exciting announcements like Proton Partners International’s, which will further cement its reputation as a world leading hub in medical and life sciences research.”
Mike Moran, chief executive officer of Proton Partners International, said: “I am delighted to announce that our fourth UK centre is to be in my home city of Liverpool.
“Not only will we be bringing the top cancer technology to the North West, but we will be located at heart of what will be a world-class destination for science, innovation, education and technology.
“This investment will not only enhance the level of cancer treatment available to patients, but will also bring skilled jobs to the area.”
It is expected The Rutherford Cancer Centres will each be able to treat up to 500 patients a year and treatment will be available to medically-insured private patients, self-paying patients and patients referred by the NHS.
Proton Partners International is also building a genomics research centre at the Life Sciences Accelerator building in Liverpool which will be the first part of a health campus set to surround the £335m new Royal Liverpool Hospital. The genomics programme will support Proton Partners International’s broader research work with the University of Liverpool’s Physics Department.